D. D’Angelo

发表

HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma.

A. Fusco, I. Martins, F. Esposito, 2016, Oncotarget.

Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity.

P. Ferranti, S. Formisano, F. Gentile, 2009, The Biochemical journal.

HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents

C. Croce, A. Fusco, R. Pacelli, 2011, Oncogene.

Identification and Synthesis of Mycalol Analogues with Improved Potency against Anaplastic Thyroid Carcinoma Cell Lines.

A. Fusco, A. Fontana, A. Cutignano, 2017, Journal of natural products.

RPSAP52 lncRNA inhibits p21Waf1/CIP expression by interacting with the RNA binding protein HuR.

A. Fusco, C. Arra, D. D’Angelo, 2019, Oncology research.

RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins

D. Solari, P. Cappabianca, A. Fusco, 2019, Journal of Molecular Medicine.

Mycalol: a natural lipid with promising cytotoxic properties against human anaplastic thyroid carcinoma cells.

A. Fusco, A. Fontana, A. Cutignano, 2013, Angewandte Chemie.

A Single Chondroitin 6-Sulfate Oligosaccharide Unit at Ser-2730 of Human Thyroglobulin Enhances Hormone Formation and Limits Proteolytic Accessibility at the Carboxyl Terminus

P. Ferranti, S. Formisano, F. Gentile, 2006, Journal of Biological Chemistry.

High Mobility Group A (HMGA): Chromatin Nodes Controlled by a Knotty miRNA Network

G. Manfioletti, R. Sgarra, Silvia Pegoraro, 2020, International journal of molecular sciences.

Emerging Role of USP8, HMGA, and Non-Coding RNAs in Pituitary Tumorigenesis

A. Fusco, C. Arra, Marco De Martino, 2019, Cancers.

Critical role of HMGA proteins in cancer cell chemoresistance

A. Fusco, C. Arra, Paula Mussnich, 2017, Journal of Molecular Medicine.

HMGA1-pseudogene expression is induced in human pituitary tumors

A. Fusco, F. Esposito, M. Jaffrain-Rea, 2015, Cell cycle.

CBX7 and HMGA1b proteins act in opposite way on the regulation of the SPP1 gene expression

A. Fusco, P. Pallante, A. U. Bastos, 2015, Oncotarget.

High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs

A. Fusco, G. Tortora, R. Bianco, 2014, BMC Cancer.

The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR‐603 and miR‐10b expression

C. Croce, A. Fusco, V. Leone, 2013, Molecular oncology.

The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin.

A. Fusco, M. D’Incalci, F. Esposito, 2013, European journal of cancer.

Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis

A. Fusco, A. Wierinckx, M. Fedele, 2012, Oncogene.

Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.

C. Croce, A. Fusco, A. Wierinckx, 2012, The Journal of clinical endocrinology and metabolism.

Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors

A. Fusco, M. Jaffrain-Rea, A. Wierinckx, 2015, Cell cycle.

Epigenetic Mechanisms Leading to Overexpression of HMGA Proteins in Human Pituitary Adenomas

A. Fusco, F. Esposito, D. D’Angelo, 2015, Front. Med..

miR-23b and miR-130b expression is downregulated in pituitary adenomas

J. Lachuer, A. Fusco, M. Jaffrain-Rea, 2014, Molecular and Cellular Endocrinology.

Thyrotropin regulates thyroid cell proliferation by up-regulating miR-23b and miR-29b that target SMAD3.

C. Croce, A. Fusco, P. Pallante, 2012, The Journal of clinical endocrinology and metabolism.

Protein-coding regions prediction combining similarity searches and conservative evolutionary properties of protein-coding sequences.

L Milanesi, L. Milanesi, I. Rogozin, 1999, Gene.

GeneBuilder: interactive in silico prediction of gene structure

Luciano Milanesi, Igor B. Rogozin, D. D'Angelo, 1999, Bioinform..

MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1

A. Fusco, R. Bianco, Paula Mussnich, 2015, Expert opinion on therapeutic targets.

MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha.

A. Fusco, G. Medeiros-Neto, P. Pallante, 2011, The Journal of clinical endocrinology and metabolism.

A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma

D. Cavalieri, P. Ostano, M. D’Incalci, 2012, PloS one.

Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells

G. Falco, M. Ceccarelli, G. Viglietto, 2016, Oncotarget.

The Long Non-Coding RNA RP5-1024C24.1 and Its Associated-Gene MPPED2 Are Down-Regulated in Human Thyroid Neoplasias and Act as Tumour Suppressors

A. Fusco, L. del Vecchio, M. Raia, 2018, Cancers.

RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins

D. Solari, P. Cappabianca, A. Fusco, 2019, Journal of Molecular Medicine.

A TSH-CREB1-microRNA loop is required for thyroid cell growth.

C. Croce, M. Santoro, A. Fusco, 2011, Molecular endocrinology.

MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1

A. Fusco, R. Bianco, Paula Mussnich, 2015, Expert opinion on therapeutic targets.

Correction: Sepe et al. The Long Non-Coding RNA RP5-1024C24.1 and Its Associated-Gene MPPED2 Are Down-Regulated in Human Thyroid Neoplasias and Act as Tumour Suppressors. Cancers 2018, 10, 146

A. Fusco, L. del Vecchio, M. Raia, 2023, Cancers.